BXCL-501
Total Payments
$81,795
Transactions
14
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $81,795 | 14 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $81,795 | 14 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| BXCL501401 | BioXcel Therapeutics, Inc. | $81,795 | 0 |
Top Doctors Receiving Payments for BXCL-501
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Desoto, TX | $81,795 | 14 |
Ad
Manufacturing Companies
- BioXcel Therapeutics, Inc. $81,795
Product Information
- Type Drug
- Total Payments $81,795
- Total Doctors 0
- Transactions 14
About BXCL-501
BXCL-501 is a drug associated with $81,795 in payments to 0 healthcare providers, recorded across 14 transactions in the CMS Open Payments database. The primary manufacturer is BioXcel Therapeutics, Inc..
Payment data is available from 2024 to 2024. In 2024, $81,795 was paid across 14 transactions to 0 doctors.
The most common payment nature for BXCL-501 is "Unspecified" ($81,795, 100.0% of total).
BXCL-501 is associated with 1 research study, including "BXCL501401" ($81,795).